TABLE 3

Estimated serologic protection for women aged 15 to 39 years from tetanus by parity and number of tetanus toxoid doses reported in Cambodia in 2012

Parity and no. of dosesaTotal no.SeroprotectedbAntibody level (IU/ml)
No.%LCLcUCLdMedianIQRe
Parous
    0130937463830.580.01–4.05
    11091009589972.370.25–7.43
    2196194100971004.640.75–12.20
    32422379896994.501.38–8.60
    431331099981005.611.67–12.43
    5+365364100981005.562.04–9.95
Nulliparous
    02871294437510.010.00–0.03
    1122907867850.130.01–1.75
    21261098578911.740.08–9.49
    31321168778921.690.25–5.71
    41221159589983.650.45–6.35
  • a Total tetanus toxoid doses received until last birth if parous, or ever if nulliparous, as assessed by card or recall.

  • b Tested by DAE, where seroprotected is defined as ≥0.01 IU/ml.

  • c LCL, lower confidence limit.

  • d UCL, upper confidence limit.

  • e IQR, interquartile range.